TY - JOUR
T1 - Interferon-γ-induced neuronal differentiation of human umbilical cord blood-derived progenitors
AU - Arien-Zakay, H.
AU - Lecht, S.
AU - Bercu, M. M.
AU - Amariglio, N.
AU - Rechavi, G.
AU - Galski, H.
AU - Lazarovici, P.
AU - Nagler, A.
PY - 2009/10
Y1 - 2009/10
N2 - Human umbilical cord blood (HUCB) provides a source of progenitors for cell therapy. We isolated and characterized an HUCB-derived population of progenitors (HUCBNP), differentiated toward neuronal phenotype by human neuroblastoma-conditioning medium (CM) and nerve growth factor (NGF), which have been found to confer neuroprotection toward hypoxia-mediated neuronal injury. This study investigated whether interferon-γ (IFN-γ) contributes to HUCBNP differentiation. IFN-γ was detected in the CM used for the induction of differentiation of HUCBNP and a neutralizing antibody of IFN-γ significantly inhibited either IFN-γ or CM-induced differentiation. Transcriptome analysis of CM-differentiated HUCBNP, identified 86 genes as highly upregulated, among them 25 were IFN-induced (such as 2′,5′-oligoadenylate synthetase 1 and 2, IFN-induced protein and transmembrane proteins, STAT1 (IFN-γ-receptor signal transducer and activator of transcription) and chemokine C-X-C motif ligand 5). Treatment of HUCBNP with human recombinant IFN-γ, inhibited cell proliferation in a dose-dependent manner. IFN-γ (1-100ng/ml) enhanced neuronal differentiation, expressed by neurite outgrowths and increased expression of the neuronal markers β-tubulin III, microtubule-associated protein 2, neuronal nuclei, neurofilament M and neuronal-specific enolase. IFN-γ additively cooperated with NGF to induce the differentiation of HUCBNP. These data indicate that IFN-γ promotes neuronal differentiation of HUCB-derived progenitors, proposing its use in future protocols towards cell therapy.
AB - Human umbilical cord blood (HUCB) provides a source of progenitors for cell therapy. We isolated and characterized an HUCB-derived population of progenitors (HUCBNP), differentiated toward neuronal phenotype by human neuroblastoma-conditioning medium (CM) and nerve growth factor (NGF), which have been found to confer neuroprotection toward hypoxia-mediated neuronal injury. This study investigated whether interferon-γ (IFN-γ) contributes to HUCBNP differentiation. IFN-γ was detected in the CM used for the induction of differentiation of HUCBNP and a neutralizing antibody of IFN-γ significantly inhibited either IFN-γ or CM-induced differentiation. Transcriptome analysis of CM-differentiated HUCBNP, identified 86 genes as highly upregulated, among them 25 were IFN-induced (such as 2′,5′-oligoadenylate synthetase 1 and 2, IFN-induced protein and transmembrane proteins, STAT1 (IFN-γ-receptor signal transducer and activator of transcription) and chemokine C-X-C motif ligand 5). Treatment of HUCBNP with human recombinant IFN-γ, inhibited cell proliferation in a dose-dependent manner. IFN-γ (1-100ng/ml) enhanced neuronal differentiation, expressed by neurite outgrowths and increased expression of the neuronal markers β-tubulin III, microtubule-associated protein 2, neuronal nuclei, neurofilament M and neuronal-specific enolase. IFN-γ additively cooperated with NGF to induce the differentiation of HUCBNP. These data indicate that IFN-γ promotes neuronal differentiation of HUCB-derived progenitors, proposing its use in future protocols towards cell therapy.
UR - http://www.scopus.com/inward/record.url?scp=70350107528&partnerID=8YFLogxK
U2 - 10.1038/leu.2009.106
DO - 10.1038/leu.2009.106
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 19458627
AN - SCOPUS:70350107528
SN - 0887-6924
VL - 23
SP - 1790
EP - 1800
JO - Leukemia
JF - Leukemia
IS - 10
ER -